These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study. Vonkeman HE, Fernandes RW, van der Palen J, van Roon EN, van de Laar MA. Arthritis Res Ther; 2007 Apr; 9(3):R52. PubMed ID: 17521422 [Abstract] [Full Text] [Related]
8. Outcome of peptic ulcer bleeding among users of traditional non-steroidal anti-inflammatory drugs and selective cyclo-oxygenase-2 inhibitors. Thomsen RW, Riis A, Christensen S, McLaughlin JK, Sørensen HT. Aliment Pharmacol Ther; 2006 Nov 15; 24(10):1431-8. PubMed ID: 17032286 [Abstract] [Full Text] [Related]
12. [Hemorrhaging eso-gastro-duodenal ulcers: epidemiology and management. A multicenter prospective study]. Nousbaum JB, Hochain P, Kerjean A, Rudelli A, Lalaude O, Herman H, Czernichow P, Dupas JL, Amouretti M, Gouerou H, Colin R. Ann Chir; 1999 Nov 15; 53(10):942-8. PubMed ID: 10670138 [Abstract] [Full Text] [Related]
15. [Prevalence and incidence of NSAID-induced gastrointestinal ulcers and bleeding]. Yamagata M, Hiraishi H. Nihon Rinsho; 2007 Oct 15; 65(10):1749-53. PubMed ID: 17926519 [Abstract] [Full Text] [Related]
16. Introduction of newer selective cyclo-oxygenase-2 inhibitors and rates of hospitalization with bleeding and perforated peptic ulcer. Christensen S, Riis A, Nørgaard M, Thomsen RW, Sørensen HT. Aliment Pharmacol Ther; 2007 Apr 15; 25(8):907-12. PubMed ID: 17402994 [Abstract] [Full Text] [Related]